PubMed

Evolving European guidance on the medical management of neovascular age related macular degeneration.

Chakravarthy U, Soubrane G, Bandello F, Chong V, Creuzot-Garcher C, Dimitrakos SA 2nd, Korobelnik JF, Larsen M, Monés J, Pauleikhoff D, Pournaras CJ, Staurenghi G, Virgili G, Wolf S.

Br J Ophthalmol. 2006 Sep;90(9):1188-96.PMID: 16929063 [PubMed - indexed for MEDLINE]Related articlesFree article

[The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD]

Pauleikhoff D, Bornfeld N, Gabel VP, Holz F, Roider H; German Ophthalmological Society; Retinological Society; Professional Association of Ophthalmologists.

Klin Monbl Augenheilkd. 2005 May;222(5):381-8. Review. German. PMID: 15912454 [PubMed - indexed for MEDLINE]Related articles

[Comments on current therapeutic possibilities for neovascular age-related macula degeneration]

[No authors listed]

Klin Monbl Augenheilkd. 2006 Apr;223(4):271-8. German. PMID: 16639662 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.

Verteporfin Roundtable Participants.

Retina. 2005 Feb-Mar;25(2):119-34. Review.PMID: 15689800 [PubMed - indexed for MEDLINE]Related articles

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.

Verteporfin Roundtable 2000 and 2001 Participants; Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group principal investigators; Verteporfin in photodynamic therapy (VIP) study group principal investigators.

Retina. 2002 Feb;22(1):6-18. Review.PMID: 11884872 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2002 Nov;120(11):1443-54.PMID: 12427056 [PubMed - indexed for MEDLINE]Related articles

Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A.

Health Technol Assess. 2008 May;12(16):iii-iv, ix-201. Review.PMID: 18462575 [PubMed - indexed for MEDLINE]Related articlesFree article

Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.

Pieramici DJ, Bressler SB, Koester JM, Bressler NM.

Arch Ophthalmol. 2006 May;124(5):660-4.PMID: 16682587 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

[No authors listed]

Arch Ophthalmol. 1999 Oct;117(10):1329-45. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10532441 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.

Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group.

Arch Ophthalmol. 2005 Apr;123(4):448-57.PMID: 15824216 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.

Arch Ophthalmol. 2001 Feb;119(2):198-207.PMID: 11176980 [PubMed - indexed for MEDLINE]Related articles

[Treatment of neovascular age-related macular degeneration with antiangiogenic drugs]

Rodrigues EB, Rossi EE, Grumann Junior A, Meyer CH, Ho AC.

Arq Bras Oftalmol. 2006 Sep-Oct;69(5):756-65. Review. Portuguese. PMID: 17187150 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

Verteporfin In Photodynamic Therapy Study Group.

Am J Ophthalmol. 2001 May;131(5):541-60.PMID: 11336929 [PubMed - indexed for MEDLINE]Related articles

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group.

Ophthalmology. 2009 Jan;116(1):57-65.e5.PMID: 19118696 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.

Hamon F, Goeminne P.

Semin Ophthalmol. 2001 Dec;16(4):223-32.PMID: 15513445 [PubMed - indexed for MEDLINE]Related articles

A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.

Brown GC, Brown MM, Brown HC, Kindermann S, Sharma S.

Ophthalmology. 2007 Jun;114(6):1170-8. Epub 2007 Feb 23.PMID: 17320964 [PubMed - indexed for MEDLINE]Related articles

Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Emerson MV, Lauer AK.

BioDrugs. 2007;21(4):245-57. Review.PMID: 17628122 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization.

Frennesson CI.

Acta Ophthalmol Scand. 2004 Dec;82(6):651-5.PMID: 15606459 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles